Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome – a prospective randomized double-blind clinical trial

Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome – a prospective randomized double-blind clinical trial

Abstract Background Ovarian hyperstimulation syndrome remains a serious complication during in vitro fertilization cycles if high dose human chorionic gonadotropin (hCG) is used to trigger ovulation in high responder patients. Though much of this risk is mitigated with trigger using gonadotropin rel...

Full description

Bibliographic Details
Main Authors: L. L. Engmann, B. S. Maslow, L. A. Kaye, D. W. Griffin, A. J. DiLuigi, D. W. Schmidt, D. R. Grow, J. C. Nulsen, C. A. Benadiva
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Journal of Ovarian Research
Subjects:
Dual trigger
Leuprolide trigger
Gonadotropin-releasing hormone agonist
Ovarian hyperstimulation syndrome
OHSS
Low dose human chorionic gonadotropin
Online Access:http://link.springer.com/article/10.1186/s13048-019-0483-7

Internet

http://link.springer.com/article/10.1186/s13048-019-0483-7

Similar Items